M 272 (Quinapril 40 mg)

Pill imprint M 272 has been identified as Quinapril hydrochloride 40 mg.

Quinapril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure; alport syndrome and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Quinapril 40 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 272

Quinapril hydrochloride 40 mg M 272
Quinapril hydrochloride 40 mg M 272
Quinapril hydrochloride
Imprint:
M
272
Strength:
40 mg
Color:
Orange
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0272
Inactive Ingredients:
silicon dioxide
crospovidone
FD&C Yellow No. 6
hypromelloses
magnesium carbonate
magnesium stearate
microcrystalline cellulose
povidone
polydextrose
polyethylene glycol
sodium lauryl sulfate
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)